Modeling the transmission risk of emerging infectious diseases through blood transfusion

Transfusion

Volumn 53, Issue 7, 2013, Pages 1421-1428

  Oei, Welling ^a   Janssen, Mart P ^a   Van Der Poel, Cees L ^a   Van Steenbergen, Jim E ^a   Rehmet, Sybille ^a   Kretzschmar, Mirjam E E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; CHIKUNGUNYA; INFECTION CONTROL; INFECTION RISK; ITALY;

BLOOD TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; HUMANS; RISK ASSESSMENT;

EID: 84880212157     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03941.x     Document Type: Article

References (17)

1. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY,. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49 Suppl 2: 1S-29S.
2. Alter HJ, Stramer SL, Dodd RY,. Emerging infectious diseases that threaten the blood supply. Semin Hematol 2007; 44: 32-41.
3. Allain JP,. Emerging viruses in blood transfusion. Vox Sang 1998; 74 Suppl 2: 125-129.
4. Petersen LR, Stramer SL, Powers AM,. Chikungunya virus: possible impact on transfusion medicine. Transfus Med Rev 2010; 24: 15-21.
5. Allain JP,. Transfusion risks of yesterday and of today. Transfus Clin Biol 2003; 10: 1-5.
6. Perkins HA, Busch MP,. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010; 50: 2080-2099.
7. Biggerstaff BJ, Petersen LR,. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003; 43: 1007-1017.
8. Dobra SA, Bennett PG,. vCJD and blood transfusion: risk assessment in the United Kingdom. Transfus Clin Biol 2006; 13: 307-311.
9. Liumbruno GM, Calteri D, Petropulacos K, Mattivi A, Po C, Macini P, Tomasini I, Zucchelli P, Silvestri AR, Sambri V, Pupella S, Catalano L, Piccinini V, Calizzani G, Grazzini G,. The chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus 2008; 6: 199-210.
10. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A,; CHIKV Study Group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007; 370: 1840-1846.
11. Angelini P, Macini P, Finarelli AC, Pol C, Venturelli C, Bellini R, Dottori M,. Chikungunya epidemic outbreak in Emilia-Romagna (Italy) during summer 2007. Parassitologia 2008; 50: 97-98.
12. Kleinman SH, Lelie N, Busch MP,. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49: 2454-2489.
13. Briggs A, Claxton K, Schulpher M,. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
14. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M,. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007; 7: 319-327.
15. Custer B, Busch MP, Marfin AA, Petersen LR,. The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Ann Intern Med 2005; 143: 486-492.
16. Agapova M, Busch MP, Custer B,. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion 2010; 50: 2220-2232.
17. Kleinman S, Cameron C, Custer B, Busch M, Katz L, Kralj B, Matheson I, Murphy K, Preiksaitis J, Devine D,. Modeling the risk of an emerging pathogen entering the Canadian blood supply. Transfusion 2010; 50: 2592-2606.